Fri, April 12, 2019
Thu, April 11, 2019
Wed, April 10, 2019
Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019
Thu, March 28, 2019
Wed, March 27, 2019
Tue, March 26, 2019
Mon, March 25, 2019
Fri, March 22, 2019
Thu, March 21, 2019
Wed, March 20, 2019
Tue, March 19, 2019
Mon, March 18, 2019
Fri, March 15, 2019
Thu, March 14, 2019
Wed, March 13, 2019
Tue, March 12, 2019
Mon, March 11, 2019
Fri, March 8, 2019

Alethia Young Maintained (ASND) at Buy with Decreased Target to $139 on, Mar 29th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-139-on-mar-29th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $151 to $139 on, Mar 29th, 2019.

Alethia has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Joseph Schwartz of "Leerink Swann" Upgraded from Hold to Buy and Increased Target to $90 on, Thursday, January 24th, 2019

Publication Contributing Sources